Related references
Note: Only part of the references are listed.Impact of prognostic factor distributions on mortality disparities for socioeconomically disadvantaged cancer patients
Yan Lu et al.
ANNALS OF EPIDEMIOLOGY (2022)
A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer
Christian Lewinter et al.
EUROPEAN HEART JOURNAL (2022)
Tobacco Product Use Among Adults — United States, 2020
Monica E. Cornelius et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
A Framework for Descriptive Epidemiology
Catherine R. Lesko et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2022)
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
N. Bouwer et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing events
Regina Stegherr et al.
PHARMACEUTICAL STATISTICS (2021)
Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies
Naomi Dempsey et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy A Randomized Clinical Trial
Lorenzo Livi et al.
JAMA ONCOLOGY (2021)
Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease-A Meta-Analysis
Raluca Mincu et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Extending inferences from a randomized trial to a new target population
Issa J. Dahabreh et al.
STATISTICS IN MEDICINE (2020)
Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings
Joseph M. Unger et al.
JAMA NETWORK OPEN (2020)
Let the question determine the methods: descriptive epidemiology done right
Sara Conroy et al.
BRITISH JOURNAL OF CANCER (2020)
Diversity and inclusion for theAll of Usresearch program: A scoping review
Brandy M. Mapes et al.
PLOS ONE (2020)
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines
Joachim Alexandre et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Target Validity: Bringing Treatment of External Validity in Line with Internal Validity
Catherine R. Lesko et al.
CURRENT EPIDEMIOLOGY REPORTS (2020)
Optimal duration of adjuvant trastuzumab in treatment of early breast cancer: a meta-analysis of randomized controlled trials
Saroj Niraula et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Short-duration versus 1-year adjuvant trastuzumab in early HER2 positive breast cancer: A meta-analysis of randomized controlled trials
Lujia Chen et al.
CANCER TREATMENT REVIEWS (2019)
Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
Anne Julienne Genuino et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
Wafaa S. El-Sherbeny et al.
JOURNAL OF ECHOCARDIOGRAPHY (2019)
Anthracycline Chemotherapy-Induced Cardiotoxicity in Breast Cancer Survivors: A Systematic Review
Katherine Jinghua Lin et al.
ONCOLOGY NURSING FORUM (2019)
Participation and retention can be high in randomized controlled trials targeting underserved populations: a systematic review and meta-analysis
Rohit P. Ojha et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Cardiac Toxicity from Breast Cancer Treatment: Can We Avoid This?
Jesse Caron et al.
CURRENT ONCOLOGY REPORTS (2018)
When to Censor?
Catherine R. Lesko et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
Generalizing Study Results A Potential Outcomes Perspective
Catherine R. Lesko et al.
EPIDEMIOLOGY (2017)
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cardiovascular Complications of Cancer Therapy Best Practices in Diagnosis, Prevention, and Management: Part 1
Hui-Ming Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Cardio-oncology in the older adult
Prajwal Reddy et al.
JOURNAL OF GERIATRIC ONCOLOGY (2017)
Duration of adjuvant trastuzumab in HER2 positive breast cancer: Overall and disease free survival results from meta-analyses of randomized controlled trials
Bishal Gyawali et al.
CANCER TREATMENT REVIEWS (2017)
Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up
Hari K. Narayan et al.
CIRCULATION (2017)
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer
Stefania Mantarro et al.
INTERNAL AND EMERGENCY MEDICINE (2016)
Applicable or non-applicable: investigations of clinical heterogeneity in systematic reviews
Laura E. Chess et al.
BMC MEDICAL RESEARCH METHODOLOGY (2016)
Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management
Giuseppe Curigliano et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Competing risk bias was common in Kaplan-Meier risk estimates published in prominent medical journals
Carl van Walraven et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
Charles Guenancia et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Risk of Congestive Heart Failure in Early Breast Cancer Patients Undergoing Adjuvant Treatment With Trastuzumab: A Meta-Analysis
Hui-Dong Long et al.
ONCOLOGIST (2016)
Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer
Megan E. V. Caram et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Trastuzumab-induced cardiotoxicity in elderly women with HER-2-positive breast cancer: a meta-analysis of real-world data
Henry W. C. Leung et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Smoking and mortality after breast cancer diagnosis: the health and functioning in women study
Monika Izano et al.
CANCER MEDICINE (2015)
Risk of cardiovascular adverse events from trastuzumab (Herceptin®) in elderly persons with breast cancer: a population-based study
H. -T. Tsai et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Cardiac Effects of Anticancer Therapy in the Elderly
Melissa K. Accordino et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
Cancer Treatment-Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities
Nonniekaye Shelburne et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
Marzia Lotrionte et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review
Dejana Braithwaite et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2012)
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
Erin J. Aiello Bowles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Lack of Uniformity in Cardiac Assessment during Trastuzumab Therapy
Milayna Subar et al.
BREAST JOURNAL (2011)
Cardiac Toxicity Associated With Anthracycline-Containing Chemotherapy in Older Women With Breast Cancer
Xianglin L. Du et al.
CANCER (2009)
Trastuzumab-Induced Cardiomyopathy: Not as Benign as it Looks? A Retrospective Study
Maya Guglin et al.
JOURNAL OF CARDIAC FAILURE (2009)
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Interval and clinical cohort studies: Epidemiological issues
Bryan Lau et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Share Paper
